These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4607454)

  • 1. Life span of cytotoxic activity and memory activity following allogeneic skin grafting in the mouse.
    Simpson E; O'Hopp S; Wunderlich J
    Transplantation; 1974 Oct; 18(4):374-7. PubMed ID: 4607454
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 3. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of cell-mediated cytotoxicity. II. Synergism of two types of thymus dependent cells in vivo.
    Sabbadini E
    Cell Immunol; 1975 Jul; 18(1):76-87. PubMed ID: 237633
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the induction and expression of T cell-mediated immunity. I. Blocking of cell-mediated cytolysis by membrane antigens.
    Bonavida B
    J Immunol; 1974 Mar; 112(3):926-34. PubMed ID: 4544178
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolongation of skin allograft survival with antilymphocyte serum and soluble histocompatibility antigens.
    Sumerska T; Betel I; Balner H; Warren HS
    Transplantation; 1974 Jan; 17(1):1-7. PubMed ID: 4148888
    [No Abstract]   [Full Text] [Related]  

  • 7. [Extended survival of allographs in mice following the injection of transplantation antigens pre-treated with normal serum. II. Mode of action (author's transl)].
    Elie R; Lamoureux G
    Ann Immunol (Paris); 1974 Jun; 125 C(4):645-53. PubMed ID: 4615620
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactivity of lymphoid cells from mice humorally tolerant to histocompatibility antigens.
    Law LW; Appella E; Cohen J; Dean JH
    Nat New Biol; 1973 Dec; 246(154):174-6. PubMed ID: 4148456
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar PB
    Transplant Proc; 1969 Mar; 1(1):429-32. PubMed ID: 4944254
    [No Abstract]   [Full Text] [Related]  

  • 10. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.
    Zinkernagel RM; Doherty PC
    Nature; 1974 Apr; 248(5450):701-2. PubMed ID: 4133807
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
    Kedar E; Bonavida B
    J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell interactions in adoptive immune rejection of a syngeneic tumor.
    Howell SB; Dean JH; Esber EC; Llaw LW
    Int J Cancer; 1974 Nov; 14(5):662-74. PubMed ID: 4376531
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis.
    Zinkernagel RM; Doherty PC
    Nature; 1974 Oct; 251(5475):547-8. PubMed ID: 4547543
    [No Abstract]   [Full Text] [Related]  

  • 14. Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibility.
    Staines NA; Guy K; Davies DA
    Transplantation; 1974 Aug; 18(2):192-5. PubMed ID: 4602953
    [No Abstract]   [Full Text] [Related]  

  • 15. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF; Dennert G; Lennox ES
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune function in fully allogeneic mouse bone marrow chimeras.
    Krown SE; Coico R; Scheid MP; Fernandes G; Good RA
    Clin Immunol Immunopathol; 1981 May; 19(2):268-83. PubMed ID: 6452977
    [No Abstract]   [Full Text] [Related]  

  • 17. New alloantigen genetically linked to the major histocompatibility locus of the mouse.
    Davies DA; Hess M
    Nature; 1974 Jul; 250(463):228-30. PubMed ID: 4546874
    [No Abstract]   [Full Text] [Related]  

  • 18. Specificity of cell-mediated transplantation reactions. II. Studies with a sensitive assay of cell-mediated cytotoxicity.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):441-55. PubMed ID: 4137937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential induction of serum blocking activity and enhancement of skin allograft by soluble alloantigen.
    Rao VS; Bonavida B; Zighelboim J; Fahey JL
    Transplantation; 1974 Jun; 17(6):568-75. PubMed ID: 4597923
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
    Bonavida B
    J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.